Open Access

Niclosamide attenuates inflammatory cytokines via the autophagy pathway leading to improved outcomes in renal ischemia/reperfusion injury

  • Authors:
    • Lin‑Xia Zhang
    • Hui‑Juan Zhao
    • Dong‑Li Sun
    • Shan‑Lin Gao
    • Hong‑Mei Zhang
    • Xin‑Guo Ding
  • View Affiliations

  • Published online on: June 14, 2017     https://doi.org/10.3892/mmr.2017.6768
  • Pages: 1810-1816
  • Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Renal ischemia/reperfusion (I/R) injury is a debilitating condition that leads to loss renal function and damage to kidney tissue in the majority of patients with acute kidney disease. Previous studies have indicated that autophagy serves a protective function in renal I/R injury. In the present study, the effect of the anthelmintic niclosamide in the regulation of inflammatory responses in kidney I/R was investigated. A total of 40 Sprague-Dawley rats were randomly divided into the following 5 groups (n=8 in each group): Sham group; renal I/R injury; renal I/R injury plus 3‑methyladenine (3‑MA) treatment (15 mg/kg); renal I/R injury plus niclosamide (25 mg/kg); and renal I/R injury plus rapamycin (10 mg/kg). The expression levels of autophagy‑associated proteins in kidney samples obtained from rats with I/R injury were examined using reverse transcription‑quantitative polymerase chain reaction and western blotting techniques. In addition, histopathological alterations, the expression of cytokines and renal function were evaluated. Treatment with niclosamide was associated with induction of autophagy and an overall improvement in renal function. There was an increased expression of autophagosome‑associated proteins, suggesting a strong correlation between autophagy and improvement of renal function. The increased levels of anti‑inflammatory cytokines and decreased levels of pro‑inflammatory cytokines provided additional evidence that niclosamide may be effective for the treatment of renal I/R injury. Clinical studies are required to further validate the results of the present study.
View Figures
View References

Related Articles

Journal Cover

August-2017
Volume 16 Issue 2

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhang LX, Zhao HJ, Sun DL, Gao SL, Zhang HM and Ding XG: Niclosamide attenuates inflammatory cytokines via the autophagy pathway leading to improved outcomes in renal ischemia/reperfusion injury. Mol Med Rep 16: 1810-1816, 2017
APA
Zhang, L., Zhao, H., Sun, D., Gao, S., Zhang, H., & Ding, X. (2017). Niclosamide attenuates inflammatory cytokines via the autophagy pathway leading to improved outcomes in renal ischemia/reperfusion injury. Molecular Medicine Reports, 16, 1810-1816. https://doi.org/10.3892/mmr.2017.6768
MLA
Zhang, L., Zhao, H., Sun, D., Gao, S., Zhang, H., Ding, X."Niclosamide attenuates inflammatory cytokines via the autophagy pathway leading to improved outcomes in renal ischemia/reperfusion injury". Molecular Medicine Reports 16.2 (2017): 1810-1816.
Chicago
Zhang, L., Zhao, H., Sun, D., Gao, S., Zhang, H., Ding, X."Niclosamide attenuates inflammatory cytokines via the autophagy pathway leading to improved outcomes in renal ischemia/reperfusion injury". Molecular Medicine Reports 16, no. 2 (2017): 1810-1816. https://doi.org/10.3892/mmr.2017.6768